Human cytomegalovirus inhibits antigen presentation by a sequential multistep process., Proc Natl Acad Sei US A 93, pp.10990-10995, 1996. ,
DOI : 10.1073/pnas.93.20.10990
Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator, Nature, vol.391, issue.6672, pp.210-86, 1998. ,
DOI : 10.1038/32472
Human B Cell Interleukin 10, Leukemia & Lymphoma, vol.80, issue.3-4, pp.1289-98, 1992. ,
DOI : 10.1172/JCI114678
Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor, Blood, vol.82, pp.2169-74, 1993. ,
Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells, The Journal of Experimental Medicine, vol.59, issue.5, pp.855-66, 1998. ,
DOI : 10.1146/annurev.immunol.15.1.675
Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10, Journal of Experimental Medicine, vol.177, issue.2, pp.295-304, 1993. ,
DOI : 10.1084/jem.177.2.295
Identification of cellular target genes of the, 1995. ,
The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif, J Virol, vol.64, pp.3358-69, 1990. ,
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus., Journal of Clinical Investigation, vol.93, issue.2, pp.768-75, 1994. ,
DOI : 10.1172/JCI117031
Epstein???Barr Virus Infection, New England Journal of Medicine, vol.343, issue.7, pp.481-92, 2000. ,
DOI : 10.1056/NEJM200008173430707
Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax, J Virol, vol.71, pp.6982-6991, 1997. ,
An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the Rand Z transactivators, J Virol, vol.64, pp.313-334, 1990. ,
IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, J Exp Med, vol.174, pp.1209-1229 ,
The third helix of the Antennapedia homeodomain translocates through biological membranes, J Biol Chem, vol.269, pp.10444-50, 1994. ,
The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization, Proc Natl Acad Sei U S A 95, pp.10072-10079, 1998. ,
DOI : 10.1073/pnas.95.17.10072
Mapping of the human IL10 gene and further characterization of the 5' flanking sequence, Immunogenetics, vol.46, issue.2, pp.120-128, 1997. ,
DOI : 10.1007/s002510050250
Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLFl immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway, J Virol, vol.74, 2000. ,
Epstein-Barr virus BZLFl trans-activator specifically binds to a consensus AP-1 site and is related to c-fos, Embo J, vol.8, pp.127-159, 1989. ,
Epstein-Barr virus BZLFl trans activator induces the promoter of a cellular cognate gene, c-fos, J Virol, vol.64, pp.4549-52, 1990. ,
Characterization of the Epstein-Barr virus BZLFl protein transactivation domain, J Virol, vol.66, pp.922-931, 1992. ,
Interleukin-10 in Epstein-Barr virus-associated post-transplant lymphomas, Clinical Transplantation, vol.324, issue.4, pp.305-317, 1999. ,
DOI : 10.1016/S0140-6736(95)91150-2
BZLFl (ZEBRA, Zta) protein of Epstein-Barr virus selected in a yeast one-hybrid system by binding to a consensus site in the IgH intronic enhancer: arole in immunoglobulin expression?, Biol Chem, vol.377, pp.669-73, 1996. ,
Les toxines bact??riennes recombinantes: de nouveaux vecteurs pour la vaccination ?, m??decine/sciences, vol.16, issue.5, pp.653-62, 2000. ,
DOI : 10.4267/10608/1708
The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effecis induction of IFN-induced genes but not the activation of transcription factor ISGF-3 [published erratum appears in, Mol Cell Biol Mol Cell Biol, vol.3, issue.12, pp.1981-4930, 1992. ,
A review of the association between interleukin-10 and human B-cell malignancies, Cancer Immunology, Immunotherapy, vol.46, issue.5, pp.239-283, 1998. ,
DOI : 10.1007/s002620050483
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide, J Immunol, vol.15, issue.9, pp.1666-1674, 1997. ,
A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi's Sarcoma-Associated Herpesvirus, Science, vol.277, issue.5332, pp.1656-1665, 1997. ,
DOI : 10.1126/science.277.5332.1656
Promotion of IL8, IL10, TNF?? and TNF?? production by EBV infection, Leukemia Research, vol.20, issue.8, pp.633-639, 1996. ,
DOI : 10.1016/0145-2126(96)00029-X
Effects of adenovirus El A protein on interferon-signaling, 1996. ,
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor, J Virol, vol.72, pp.5433-5473, 1998. ,
Responsiveness of the, 1989. ,
The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virusinfected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions, 1990. ,
Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition., Molecular and Cellular Biology, vol.17, issue.11, pp.6624-6656, 1997. ,
DOI : 10.1128/MCB.17.11.6624
Endocytosis and targeting of exogenous HIV-1 Tat protein, Embo J, vol.10, pp.1733-1742, 1991. ,
The Cowpox Virus-Encoded Homolog of the Vaccinia Virus Complement Control Protein Is an Inflammation Modulatory Protein, Virology, vol.229, issue.1, 1997. ,
DOI : 10.1006/viro.1996.8396
Human Cytomegalovirus Inhibits Major Histocompatibility Complex Class II Expression By Disruption of the Jak/Stat Pathway, The Journal of Experimental Medicine, vol.158, issue.5, pp.675-83, 1998. ,
DOI : 10.1016/S1074-7613(00)80349-0
Lymphoprolif??rations T associ??es au virus d'Epstein-Barr., m??decine/sciences, vol.14, issue.6-7, pp.690-697, 1998. ,
DOI : 10.4267/10608/1123
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?, J Virol, vol.71, pp.4187-92, 1997. ,
Intercellular delivery of functional p53 by the herpesvirus protein VP22, Nature Biotechnology, vol.39, issue.5, pp.440-443, 1998. ,
DOI : 10.1006/viro.1996.0286
The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors, Immunological Reviews, vol.271, issue.1, pp.51-63, 1999. ,
DOI : 10.1083/jcb.136.4.811
URL : https://hal.archives-ouvertes.fr/pasteur-01372749
Virus d'Epstein-Barr et lymphomes. La lettre de l'infectiologue 10, pp.202-207, 1995. ,
HIV-1 Tat: immunosuppression via TGF-??1 induction, Immunology Today, vol.20, issue.8, pp.384-389, 1999. ,
DOI : 10.1016/S0167-5699(99)01497-8
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells, Nature, vol.386, issue.6624, pp.514-521, 1997. ,
DOI : 10.1038/386514a0
Epstein???Barr virus, Virus Research, vol.82, issue.1-2, 1996. ,
DOI : 10.1016/S0168-1702(01)00436-1
URL : https://hal.archives-ouvertes.fr/inserm-00508046
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES, Annual Review of Immunology, vol.17, issue.1, pp.739-79, 1999. ,
DOI : 10.1146/annurev.immunol.17.1.739
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes., Proc Natl Acad Sei US A, pp.1890-1893, 1992. ,
DOI : 10.1073/pnas.89.5.1890
Induction of Interleukin-10 on Activation of Epstein-Barr Virus in EBV-Infected B-Cell Lines, Viral Immunology, vol.11, issue.4, pp.221-252, 1998. ,
DOI : 10.1089/vim.1998.11.221
Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo, J Immunol, vol.157, pp.650-655, 1996. ,
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse, Science, vol.285, issue.5433, pp.1569-72, 1999. ,
DOI : 10.1126/science.285.5433.1569
Infection à virus d'Epstein-Barr chez l'immunodéprimé physiopatholgie et méthodes d'analyse, Virologie, vol.1, pp.391-402, 1997. ,
The Epstein-Barr virus latency and reactivation. In Cancer in Transplantation : Prevention and Treatment, J. L. Touraine, J. Traeger, H. Bétuel, J. M, 1996. ,
Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene, Trends in Microbiology, vol.5, issue.10, pp.399-405, 1997. ,
DOI : 10.1016/S0966-842X(97)01129-3
Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses, Proc Natl Acad Sei U S A 97, pp.8455-60, 2000. ,
DOI : 10.1073/pnas.150240097
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity, Cell, vol.81, issue.4, pp.551-60, 1995. ,
DOI : 10.1016/0092-8674(95)90076-4
Human and Viral Interleukin-10 in Acute Epstein-Barr Virus-Induced Infectious Mononucleosis, Journal of Infectious Diseases, vol.171, issue.5, pp.7-50, 1995. ,
DOI : 10.1093/infdis/171.5.1347
Human interleukin-10 can directly inhibit T-cell growth, Blood, vol.81, pp.2964-71, 1993. ,
Athérosclérose : les pouvoirs de !'interleukine 1 O, Inserm actualités, p.5, 2000. ,
Viral Subversion of the Immune System, Annual Review of Immunology, vol.18, issue.1, pp.861-926, 2000. ,
DOI : 10.1146/annurev.immunol.18.1.861
The Epstein-Barr virus early protein EB 1 activates transcription from different responsive elements including AP-1 binding sites, Embo J, vol.8, pp.1447-53, 1989. ,
Interleukin 10 and non Hodgkin???s lymphomas, Cancer in, pp.229-241, 1996. ,
DOI : 10.1007/978-94-009-0175-9_26
Correlation between IL-10 expression and the presence of EBV in non Hodgkin's lymphoma, Blood, vol.84, p.59, 1994. ,
Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis, J Immunol, vol.151, pp.6853-61, 1993. ,